Renal Cell Carcinoma, Clear Cell Adenocarcinoma
1 clinical trials · Condition
◉ Watch Renal Cell Carcinoma, Clear Cell Adenocarcinoma
| Record | Firm | Date |
|---|---|---|
| A Trial of Belzutifan (PT2977, MK-6482) Tablets In Patients With Advanced Solid Tumors (MK-6482-001) (NCT02974738) | Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2016-12-07 |
Track Renal Cell Carcinoma, Clear Cell Adenocarcinoma automatically
Every clearance here is in the API, with alerts when new ones post.